Soy Isoflavones and Breast Cancer Risk: A Meta-analysis

Overview

Journal In Vivo

Specialty Oncology

Date 2022 Mar 4

PMID 35241506

Authors

Ioannis Boutas

Adamantia Kontogeorgi

Constantine Dimitrakakis

Sophia N Kalantaridou

Affiliations

Soon will be listed here.

Abstract

Background/aim: Soy contains genistein and daidzein isoflavones. Isoflavones are phytoestrogens, with a similarity in structure to human 17-β estradiol hormone. They imitate the action of estrogen on organs by binding and activating estrogen receptors. Numerous studies have examined the relationship between soy consumption and breast cancer but not the amount of consumption itself. We performed a systematic review of the literature in order to determine whether the amount of soy and isoflavones consumed has a positive effect in pre- and post-menopausal women.

Materials And Methods: Data gathering was performed following PRISMA guidelines. Narrowing down the result set for all relevant data was performed via title, abstract, full-text evaluation and the snowball procedure. The selected articles had all relevant data extracted. Analysis of the data was performed using Cochrane's Review Manager statistical analysis tool in order to draw conclusions regarding the positive effect for the amount of soy and isoflavones consumed.

Results: Significant results were found when statistically analyzing data from prospective studies which compared soy isoflavones consumption, breast cancer risk and occurrence. The data were indicative of a clear inverse correlation between the amount of isoflavones consumed and breast cancer occurrence in pre- and post-menopausal women.

Conclusion: The consumption of soy isoflavones can reduce the risk of breast cancer in pre-menopausal and post-menopausal women.

Citing Articles

Isoflavones: Promising Natural Agent for Cancer Prevention and Treatment.

Ul Hassan M, Shahbaz M, Imran M, Momal U, Naeem H, Mujtaba A Food Sci Nutr. 2025; 13(3):e70091.

PMID: 40078339 PMC: 11896816. DOI: 10.1002/fsn3.70091.

Mechanism of action of genistein on breast cancer and differential effects of different age stages.

Xiang Z, Ma B, Pei X, Wang W, Gong W Pharm Biol. 2025; 63(1):141-155.

PMID: 39996512 PMC: 11864014. DOI: 10.1080/13880209.2025.2469607.

Cellular and Molecular Mechanisms Modulated by Genistein in Cancer.

Naponelli V, Piscazzi A, Mangieri D Int J Mol Sci. 2025; 26(3).

PMID: 39940882 PMC: 11818640. DOI: 10.3390/ijms26031114.

Promotion of Healthy Aging Through the Nexus of Gut Microbiota and Dietary Phytochemicals.

Beaver L, Jamieson P, Wong C, Hosseinikia M, Stevens J, Ho E Adv Nutr. 2025; 16(3):100376.

PMID: 39832641 PMC: 11847308. DOI: 10.1016/j.advnut.2025.100376.

Perspective on the Coevolutionary Role of Host and Gut Microbiota in Polyphenol Health Effects: Metabotypes and Precision Health.

Espin J, Jarrin-Orozco M, Osuna-Galisteo L, Avila-Galvez M, Romo-Vaquero M, Selma M Mol Nutr Food Res. 2024; 68(22):e2400526.

PMID: 39538982 PMC: 11605795. DOI: 10.1002/mnfr.202400526.

References

Ziaei S, Halaby R . Dietary Isoflavones and Breast Cancer Risk. Medicines (Basel). 2017; 4(2). PMC: 5590054. DOI: 10.3390/medicines4020018. View

Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S . Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst. 2003; 95(12):906-13. DOI: 10.1093/jnci/95.12.906. View

Baglia M, Zheng W, Li H, Yang G, Gao J, Gao Y . The association of soy food consumption with the risk of subtype of breast cancers defined by hormone receptor and HER2 status. Int J Cancer. 2016; 139(4):742-8. PMC: 5114023. DOI: 10.1002/ijc.30117. View

Hatono M, Ikeda H, Suzuki Y, Kajiwara Y, Kawada K, Tsukioki T . Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments. Breast Cancer Res Treat. 2020; 185(2):307-316. DOI: 10.1007/s10549-020-05957-z. View

Wei Y, Lv J, Guo Y, Bian Z, Gao M, Du H . Soy intake and breast cancer risk: a prospective study of 300,000 Chinese women and a dose-response meta-analysis. Eur J Epidemiol. 2019; 35(6):567-578. PMC: 7320952. DOI: 10.1007/s10654-019-00585-4. View

Yang S, Zhou Q, Yang X . Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells. Biochim Biophys Acta. 2007; 1773(6):903-11. DOI: 10.1016/j.bbamcr.2007.03.021. View

Ju Y, Doerge D, Allred K, Allred C, Helferich W . Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Res. 2002; 62(9):2474-7. View

Pagliacci M, Smacchia M, Migliorati G, Grignani F, Riccardi C, Nicoletti I . Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer. 1994; 30A(11):1675-82. DOI: 10.1016/0959-8049(94)00262-4. View

Setchell K, Brown N, Zhao X, Lindley S, Heubi J, King E . Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk. Am J Clin Nutr. 2011; 94(5):1284-94. PMC: 3192476. DOI: 10.3945/ajcn.111.019638. View

10.

Horn-Ross P, Hoggatt K, West D, Krone M, Stewart S, Anton H . Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control. 2002; 13(5):407-15. DOI: 10.1023/a:1015786030864. View

11.

Allred C, Allred K, Ju Y, Virant S, Helferich W . Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res. 2001; 61(13):5045-50. View

12.

Morimoto Y, Maskarinec G, Park S, Ettienne R, Matsuno R, Long C . Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the Multiethnic Cohort. Br J Nutr. 2014; 112(6):976-83. PMC: 4237401. DOI: 10.1017/S0007114514001780. View

13.

Kang H, Zhang Y, Yang J, Lu K . Study on soy isoflavone consumption and risk of breast cancer and survival. Asian Pac J Cancer Prev. 2012; 13(3):995-8. DOI: 10.7314/apjcp.2012.13.3.995. View

14.

Guo Y, Wang S, Hoot D, Clinton S . Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. J Nutr Biochem. 2006; 18(6):408-17. DOI: 10.1016/j.jnutbio.2006.08.006. View

15.

Zhang F, Haslam D, Terry M, Knight J, Andrulis I, Daly M . Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry. Cancer. 2017; 123(11):2070-2079. PMC: 5444962. DOI: 10.1002/cncr.30615. View

16.

Hedelin M, Lof M, Olsson M, Adlercreutz H, Sandin S, Weiderpass E . Dietary phytoestrogens are not associated with risk of overall breast cancer but diets rich in coumestrol are inversely associated with risk of estrogen receptor and progesterone receptor negative breast tumors in Swedish women. J Nutr. 2008; 138(5):938-45. DOI: 10.1093/jn/138.5.938. View

17.

Varinska L, Gal P, Mojzisova G, Mirossay L, Mojzis J . Soy and breast cancer: focus on angiogenesis. Int J Mol Sci. 2015; 16(5):11728-49. PMC: 4463727. DOI: 10.3390/ijms160511728. View

18.

Hirano T, Oka K, Akiba M . Antiproliferative effects of synthetic and naturally occurring flavonoids on tumor cells of the human breast carcinoma cell line, ZR-75-1. Res Commun Chem Pathol Pharmacol. 1989; 64(1):69-78. View

19.

Farina H, Pomies M, Alonso D, Gomez D . Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer. Oncol Rep. 2006; 16(4):885-91. View

20.

McPherson K, Steel C, Dixon J . ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ. 2000; 321(7261):624-8. PMC: 1118507. DOI: 10.1136/bmj.321.7261.624. View